Induction of Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients by Transient Intensive Insulin Treatment

Cited by (269)

Items 101–200 of 269

1. Noninferiority Effects on Glycemic Control and β-Cell Function Improvement in Newly Diagnosed Type 2 Diabetes Patients: Basal Insulin Monotherapy Versus Continuous Subcutaneous Insulin Infusion Treatment
   Longyi Zeng, Hongyun Lu, Hongrong Deng, Panwei Mu, Xiaofeng Li, Manman Wang · 2011 · Diabetes Technology & Therapeutics
2. Short‐term intensive insulin therapy could be the preferred option for new onset T ype 2 diabetes mellitus patients with HbA1c > 9%
   Jianping Weng · 2017 · Journal of Diabetes
3. Insulin Therapy in People Who Have Dysglycemia and Type 2 Diabetes Mellitus: Can It Offer Both Cardiovascular Protection and Beta-Cell Preservation?
   Hertzel C. Gerstein, Julio Rosenstock · 2005 · Endocrinology and Metabolism Clinics of North America
4. Real-world effectiveness of early insulin therapy on the incidence of cardiovascular events in newly diagnosed type 2 diabetes
   Sihui Luo, Xueying Zheng, Wei Bao, Sheng Nie, Yu Ding, Tong Yue, Yilun Zhou, Ying Hu, Hua Li, Qiongqiong Yang et al. · 2024 · Signal Transduction and Targeted Therapy
5. Aqueous Fraction of Beta vulgaris Ameliorates Hyperglycemia in Diabetic Mice due to Enhanced Glucose Stimulated Insulin Secretion, Mediated by Acetylcholine and GLP-1, and Elevated Glucose Uptake via Increased Membrane Bound GLUT4 Transporters
   Ashraf Ul Kabir, Mehdi Bin Samad, Ahmed Arif, Mohammad Rajib Jahan, Farjana Akhter, Jinat Tasnim, S.M. Nageeb Hasan, Sania Sarker Sayfe, J. M. A. Hannan · 2015 · PLoS ONE
6. Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial
   Feng-fei Li, Lanlan Jiang, Liyuan Fu, Honghong Zhu, Peihua Zhou, Danfeng Zhang, Xiaofei Su, Jin-dan Wu, Lei Ye, Jianhua Ma · 2016 · Diabetes Therapy
7. Beneficial effects of K‐ATP channel openers in diabetes: an update on mechanisms and clinical experiences
   Valdemar Grill, Maria Radtke, Elisabeth Qvigstad, M. Kollind, Anneli Björklund · 2009 · Diabetes Obesity and Metabolism
8. Why and How to Use Insulin Therapy Earlier in the Management of Type 2 Diabetes
   Luigi Meneghini · 2007 · Southern Medical Journal
9. Strategies for Insulin Therapy in Type 2 Diabetes
   Steven V. Edelman, Candis M. Morello · 2005 · Southern Medical Journal
10. Two‐year trial of intermittent insulin therapy vs metformin for the preservation of β‐cell function after initial short‐term intensive insulin induction in early type 2 diabetes
    Ravi R. Retnakaran, Haysook Choi, Chang Ye, Caroline Kaercher Kramer, Bernard Zinman · 2018 · Diabetes Obesity and Metabolism
11. Insulin improves β-cell function in glucose-intolerant rat models induced by feeding a high-fat diet
    Huiqing Li, Baoping Wang, Xiu‐Ling Deng, Jiaoyue Zhang, Yongbo Wang, Juan Zheng, Wenfang Xia, Tianshu Zeng, Lulu Chen · 2011 · Metabolism
12. Incidence and predictors of remission and relapse of type 2 diabetes mellitus in Japan: Analysis of a nationwide patient registry (JDDM73)
    Kazuya Fujihara, LAY MON KHIN, Koshiro Murai, Yurie Yamazaki, Kahori Tsuruoka, Noriko Yagyuda, Katsuya Yamazaki, Hiroshi Maegawa, Shiro Tanaka, Satoru Kodama et al. · 2023 · Diabetes Obesity and Metabolism
13. Fasting plasma glucose after intensive insulin therapy predicted long-term glycemic control in newly diagnosed type 2 diabetic patients
    Jianbin Liu, Juan Liu, Donghong Fang, Liehua Liu, Zhimin Huang, Xuesi Wan, Xiaopei Cao, Yanbing Li · 2013 · Endocrine Journal
14. The effect of glargine versus glimepiride on pancreatic β-cell function in patients with type 2 diabetes uncontrolled on metformin monotherapy: open-label, randomized, controlled study
    BETA study group, Jun Sung Moon, Kyoung Soo Ha, Ji Sung Yoon, Hyoung Woo Lee, Hyun Chul Lee, Kyu Chang Won · 2014 · Acta Diabetologica
15. Effects of the Modified Linggui Zhugan Decoction () Combined with Short-term Very Low Calorie Diets on Glycemic Control in Newly Diagnosed Type 2 Diabetics
    Ding-sheng CHEN, Bin Ke, Yingjuan Huang, Jun Meng, Junjie Zhang, Zexiong Chen, Andreas Michalsen, Jian Qin · 2011 · 中医杂志：英文版
16. Thiazolidinediones and Insulin
    Alvin Huang, Philip Raskin · 2005 · Treatments in Endocrinology
17. The Barriers to Initiating Insulin Therapy among People with Type 2 Diabetes in Taiwan - A Qualitative Study
    Kwang- Wen Chen, Hsu‐Min Tseng · 2012 · Journal of Diabetes & Metabolism
18. Comparing Self-Rated Health, Satisfaction and Quality of Life Scores Between Diabetics and Others Living in The Bella Coola Valley
    Angela Grigg, Harvey V. Thommasen, Hugh D. Tildesley, Alex C. Michalos · 2006 · Social Indicators Research
19. Insulin therapy in type 2 diabetes
    Rasa Kazlauskaite, Leon A. Fogelfeld · 2003 · Disease-a-Month
20. Reversal of high-glucose–induced transcriptional and epigenetic memories through NRF2 pathway activation
    Martí Wilson-Verdugo, Brandon Bustos-García, Olga Adame-Guerrero, Jaqueline Hersch-González, Nallely Cano-Domínguez, Maribel Soto-Nava, Carlos A Acosta, Teresa Tusié‐Luna, Santiago Ávila‐Ríos, Lilia Guadalupe Noriega et al. · 2024 · Life Science Alliance
21. Comparison of Gliclazide with Insulin as Initial Treatment Modality in Newly Diagnosed Type 2 Diabetes
    Satish T. Chandra, Gagan Priya, Madan Lal Khurana, Viveka P. Jyotsna, Vishnubhatla Sreenivas, Sadanand N. Dwivedi, Ariachery Chinnama Ammini · 2008 · Diabetes Technology & Therapeutics
22. Insulin and Oral Hypoglycemic Agents Should Not Be Used in Combination in the Treatment of Type 2 Diabetes
    Sydney A. Westphal, Pasquale J Palumbo · 2003 · Archives of Internal Medicine
23. The islet in type 2 diabetes: back to center stage.
    Erol Cerasi, Christian Boîtard, Suad Efendić, Eleuterio Ferrannini, Jean‐Claude Henquin, Donald F. Steiner · 2001 · Diabetes
24. Current role of short‐term intensive insulin strategies in newly diagnosed type 2 diabetes (短期胰岛素强化治疗策略对初诊2型糖尿病患者的作用)
    Wen Xu, Jianping Weng · 2013 · Journal of Diabetes
25. Comparative effectiveness of early versus delayed metformin in the treatment of type 2 diabetes
    Robert J. Romanelli, Sukyung Chung, Jia Pu, Vani C Nimbal, Beinan Zhao, Latha P Palaniappan · 2015 · Diabetes Research and Clinical Practice
26. Insulin Requirement Profiles of Patients with Type 2 Diabetes After Achieving Stabilized Glycemic Control with Short-Term Continuous Subcutaneous Insulin Infusion
    Yun-Hee Noh, Won Jin Lee, Kyoung‐Ah Kim, Inja Lim, Jun‐Ho Lee, Jeong Hyeon Lee, Seonguk Kim, Soo-Bong Choi · 2010 · Diabetes Technology & Therapeutics
27. Glycemic control releases regenerative potential of pancreatic beta cells blocked by severe hyperglycemia
    Judith Furth‐Lavi, Ayat Hija, Sharona Tornovsky-Babeay, Adi Mazouz, Tehila Dahan, Miri Stolovich-Rain, Agnes Klochendler, Yuval Dor, Dana Avrahami, Benjamin Gläser · 2022 · Cell Reports
28. Insulin glargine 300 U/ml for the treatment of feline diabetes mellitus
    Guido Linari, Linda Mary Fleeman, Chen Gilor, Lucia Giacomelli, Federico Fracassi · 2021 · Journal of Feline Medicine and Surgery
29. Type 2 diabetes mellitus: time to change the concept
    Shmuel Levit, Yury Ivanovich Philippov, Alexander Gorelyshev · 2013 · Diabetes Mellitus
30. The Pharmacist's Role in Maintaining Adherence to Insulin Therapy in Type 2 Diabetes Mellitus Clinical Review
    Eva Vivian · 2007 · The Consultant Pharmacist
31. 5′-AMP-activated protein kinase plays an essential role in geniposide-regulated glucose-stimulated insulin secretion in rat pancreatic INS-1 β cells
    Yanan Hao, Chunyan Liu, Fei Yin, Yonglan Zhang, Jianhui Liu · 2016 · Journal of Natural Medicines
32. Early use of insulin in type 2 diabetes
    Roy Eldor, E Stern, Zvonko Miličević, Itamar Raz · 2005 · Diabetes Research and Clinical Practice
33. Inhaled Insulin for Type 2 Diabetes: Solution or Distraction?
    David M. Nathan · 2001 · Annals of Internal Medicine
34. Pathophysiology, Diagnostic Criteria, and Approaches to Type 2 Diabetes Remission
    Abeer M Khamis · 2023 · Cureus
35. Effects of saxagliptin add-on therapy to insulin on blood glycemic fluctuations in patients with type 2 diabetes
    Feng-fei Li, Lanlan Jiang, Rengna Yan, Honghong Zhu, Peihua Zhou, Danfeng Zhang, Xiaofei Su, Jin-dan Wu, Lei Ye, Jianhua Ma · 2016 · Medicine
36. [Prevalence of glycemic control and associated factors in type 2 diabetes mellitus patients at the Hospital Universitario de San Ignacio, Bogotá-Colombia].
    Luz Helena Alba, Carlin Bastidas, José Manuel Vivas, Fabián Gil · 2009 · PubMed
37. When Intensive Insulin Therapy (MDI) Fails in Patients With Type 2 Diabetes: Switching to GLP-1 Receptor Agonist Versus Insulin Pump
    Ohad Cohen, Sébastiano Filetti, Javier Castañeda, Marianna Maranghi, Mariela Glandt · 2016 · Diabetes Care
38. Insulin dependent and independent normalization of blood glucose levels reduces the enhanced rewarding effects of nicotine in a rodent model of diabetes
    Javier Íbias, Laura E. O’Dell, Arbi Nazarian · 2018 · Behavioural Brain Research
39. Effects of Liraglutide Combined with Short-Term Continuous Subcutaneous Insulin Infusion on Glycemic Control and Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Pilot Study
    Weijian Ke, Liehua Liu, Juan Liu, Ailing Chen, Wanping Deng, Pengyuan Zhang, Xiaopei Cao, Zhihong Liao, Haipeng Xiao, Jianbin Liu et al. · 2015 · Journal of Diabetes Research
40. Addressing the Burden of Multiple Daily Insulin Injections in Type 2 Diabetes with Insulin Pump Technology: A Narrative Review
    Diana I Brixner, Steven V. Edelman, Ray Sieradzan, James R. Gavin · 2024 · Diabetes Therapy
41. Intensive Therapy in Newly Diagnosed Type 2 Diabetes: Results of a 6-Year Randomized Trial
    Lindsay Harrison, BEVERLEY A. ADAMS-HUET, Xilong Li, Philip Raskin, Ildiko Lingvay · 2014 · Journal of Investigative Medicine
42. Genetic Reduction of Glucose Metabolism Preserves Functional β-Cell Mass in KATP-Induced Neonatal Diabetes
    Zihan Yan, Manuela Fortunato, Zeenat A. Shyr, Amy L. Clark, Matt Fuess, Colin G. Nichols, Maria Sara Remedi · 2022 · Diabetes
43. Novel Strategies for Inducing Glycemic Remission during the Honeymoon Phase of Type 2 Diabetes
    Ravi R. Retnakaran · 2015 · Canadian Journal of Diabetes
44. Male Patients with Longstanding Type 2 Diabetes Have a Higher Incidence of Hypoglycemia Compared with Female Patients
    Feng-fei Li, Ying Zhang, Wenli Zhang, Xiaomei Liu, Mao-yuan Chen, Yixuan Sun, Xiaofei Su, Jin-dan Wu, Lei Ye, Jianhua Ma · 2018 · Diabetes Therapy
45. Baseline characteristics of the Indian cohort from the IMPROVE™ study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes
    Siddharth N Shah, A. K. Das, Ajay Kumar, A G Unnikrishnan, Sanjay Kalra, M. P. Baruah, B Ganapathi, Rakesh Kumar Sahay · 2009 · Advances in Therapy
46. Insulin therapy for type 2 diabetes
    Afshin Sasali, Jack L. Leahy · 2003 · Current Diabetes Reports
47. Balancing needs and means: the dilemma of the β‐cell in the modern world
    Gil Leibowitz, Ν. Kaiser, Erol Cerasi · 2009 · Diabetes Obesity and Metabolism
48. Continuous subcutaneous insulin infusion providing better glycemic control and quality of life in Type 2 diabetic subjects hospitalized for marked hyperglycemia
    I‐Te Lee, Yi‐Ju Liau, Wen‐Jane Lee, Chien‐Ning Huang, Wayne Huey‐Herng Sheu · 2010 · Journal of Evaluation in Clinical Practice
49. Should the last be first? Questions and dilemmas regarding early short-term insulin treatment in Type 2 Diabetes Mellitus
    Theocharis Koufakis, Spyridon Ν. Karras, Pantelis E Zebekakis, Ramzi Ajjan, Kalliopi Kotsa · 2018 · Expert Opinion on Biological Therapy
50. Plasticité anatomique et fonctionnelle des cellules β du pancréas endocrine et diabète de type 2
    Erol Cerasi, Alain Ktorza · 2007 · médecine/sciences
51. Remission of type 2 diabetes: A critical appraisal
    Michele Ricci, Juan José Mancebo-Sevilla, Lidia Cobos-Palacios, Jaime Sanz‐Cánovas, Almudena López Sampalo, Halbert Hernández-Negrín, Miguel Ángel Pérez Velasco, Luis Miguel Perez-Belmonte, María Rosa Bernal-López, Ricardo Gómez‐Huelgas · 2023 · Frontiers in Endocrinology
52. Beta‐cell function in type 2 diabetes ( T2DM ): Can it be preserved or enhanced?
    Laure Sayyed Kassem, Aman Rajpal, Margarita Victoria Ebarle Barreiro, Faramarz Ismail‐Beigi · 2023 · Journal of Diabetes
53. Effect of 24-week treatment with ipragliflozin on proinsulin/C-peptide ratio in Japanese patients with type 2 diabetes
    Yoshio Nagai, Akio Ohta, Yukiyoshi Sada, Hiroyuki Kato, Yasushi Tanaka · 2016 · Expert Opinion on Pharmacotherapy
54. Initial Combination with Linagliptin and Metformin in Newly Diagnosed Type 2 Diabetes and Severe Hyperglycemia
    Thomas Haak · 2012 · Advances in Therapy
55. Basal Insulin Requirements on Continuous Subcutaneous Insulin Infusion during the First 12 Months after Diagnosis of Type 1 Diabetes Mellitus
    Neesha Ramchandani, Mary Kristine Ellis, Shobhit Jain, Sonal Bhandari, Henry Anhalt, Noel Keith Maclaren, Svetlana Ten · 2010 · Journal of Diabetes Science and Technology
56. Combination Therapy in Type 2 Diabetes
    Mandeep Bajaj, Ralph Anthony DeFronzo · 2004 · Wiley eBooks
57. Induction of remission in diabetes by lowering blood glucose
    Gordon C. Weir, Susan Bonner‐Weir · 2023 · Frontiers in Endocrinology
58. Effect of exenatide after short-time intensive insulin therapy on glycaemic remission maintenance in type 2 diabetes patients: a randomized controlled trial
    Xiulin Shi, Yalin Shi, Ning Chen, Mingzhu Lin, Weijuan Su, Huijie Zhang, Changqin Liu, Haiqu Song, Fangsen Xiao, Peiying Huang et al. · 2017 · Scientific Reports
59. Improvement of β‐cell function after achievement of optimal glycaemic control via long‐term continuous subcutaneous insulin infusion therapy in non‐newly diagnosed type 2 diabetic patients with suboptimal glycaemic control
    Soo‐Bong Choi, Jun‐Ho Lee, Jeong Hyeon Lee, Seonguk Kim, Sang‐Don Han, Ickhee Kim, Yun‐Hee Noh · 2013 · Diabetes/Metabolism Research and Reviews
60. Basic Approach to Managing Hyperglycemia for the Nonendocrinologist
    Mark A. Deeg · 2005 · The American Journal of Cardiology
61. Insulin pump therapy for type 2 diabetes
    Susan E. Kirk · 2003 · Current Diabetes Reports
62. Overcoming barriers to glycemic control in African Americans with type-2 diabetes: benefits of insulin therapy.
    M Marshall · 2007 · PubMed Central
63. Intensive Intravenous Infusion of Insulin in Diabetic Cats
    M. Häfner, S. Dietiker‐Moretti, K. Kaufmann, C. Mueller, Thomas A. Lutz, Claudia E Reusch, Eric Zini · 2014 · Journal of Veterinary Internal Medicine
64. Weight change in patients with new‐onset type 2 diabetes mellitus and its association with remission: Comprehensive real‐world data
    Jinyoung Kim, Bongseong Kim, Mee Kyoung Kim, Ki‐Hyun Baek, Ki‐Ho Song, Kyungdo Han, Hyuk‐Sang Kwon · 2023 · Diabetes Obesity and Metabolism
65. The Effect of Early Intensive Insulin Therapy on Body Fat Distribution andβ-Cell Function in Newly Diagnosed Type 2 Diabetes
    Jang Won Son, Hee Kyoung Jeong, Seong Su Lee, Sung Rae Kim, Bong‐Yun Cha, Ho‐Young Son, Soon Jib Yoo · 2013 · Endocrine Research
66. Fasting Plasma Glucose Indicates Reversibility of the Acute Insulin Response after Short-Term Intensive Insulin Therapy in Patients with Various Duration of Type 2 Diabetes
    Liehua Liu, S. Yang, Jianbin Liu, Hai Li, Juan Liu, Xiaopei Cao, Haipeng Xiao, Yanbing Li · 2018 · Journal of Diabetes Research
67. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes
    Xubin Yang, Hongrong Deng, Xiuzhen Zhang, Daizhi Yang, Jinhua Yan, Bin Yao, Jianping Weng, Wen Xu · 2019 · Science China Life Sciences
68. Weight Gain and Management Concerns in Patients on Insulin Therapy
    Sydney A. Westphal, Pasquale J Palumbo · 2007 · Insulin
69. Optimising Therapy for Insulin-Treated Type 2 Diabetes Mellitus
    L. S. Hermann · 2000 · Drugs & Aging
70. Pharmacotherapy of Diabetes Mellitus: Implications for the Prevention and Treatment of Cardiovascular Disease
    Enzo Ragucci, Joel Zonszein, William H. Frishman · 2003 · Heart Disease
71. Young onset type 2 diabetic patients might be more sensitive to metformin compared to late onset type 2 diabetic patients
    Feng-fei Li, Bing-li Liu, Guo‐ping Yin, Danfeng Zhang, Xiao‐fang Zhai, Mao-yuan Chen, Xiaofei Su, Jin-dan Wu, Lei Ye, Jianhua Ma · 2017 · Scientific Reports
72. Remission with an Intervention
    Zubaidah Nor Hanipah, Francesco Rubino, Philip R. Schauer · 2023 · Endocrinology and Metabolism Clinics of North America
73. Preserving insulin secretion in Type 2 diabetes mellitus
    Joseph M. Tibaldi · 2008 · Expert Review of Endocrinology & Metabolism
74. Investigation of the Insulin Dose and Characteristics of Continuous Subcutaneous Insulin Infusion in Chinese People with Type 2 Diabetes
    Guan-Qi Gao, Qing-Yu Dong, Shou-Jie Li, Yuanyuan Zhang, Wenxia Li, Wenhua Du, Cuige Liang, Yue-Li Wang · 2011 · Diabetes Technology & Therapeutics
75. Reevaluating Goals of Insulin Therapy: Perspectives from Large Clinical Trials
    Matthew C. Riddle, Kevin C.J. Yuen · 2012 · Endocrinology and Metabolism Clinics of North America
76. Influence of adenosine on preservation of porcine pancreas in islet transplantation
    Wanting Song, Dazhi Fu, Yu‐Fan Cheng, Y.F. Liu · 2015 · Genetics and Molecular Research
77. Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
    Feng-fei Li, Bing-li Liu, Guo‐ping Yin, Rengna Yan, Danfeng Zhang, Jin-dan Wu, Lei Ye, Xiaofei Su, Jianhua Ma · 2018 · Scientific Reports
78. β-Cell Dysfunction and Death
    DéScio L. Eizirik, Anne Hoorens · 1999 · Advances in molecular and cell biology
79. Continuous subcutaneous insulin infusion: short-term benefits apparent, long-term benefits speculative
    Peter J. Hammond · 2004 · The British Journal of Diabetes
80. Controversies in Treating Diabetes
    Derek LeRoith, Aaron I. Vinik · 2008 · Humana Press eBooks
81. Is There a Rationale for Insulin Therapy in Pre-Diabetic Individuals?
    Sherwyn Leon Schwartz · 2006 · Treatments in Endocrinology
82. Insulin Therapy in Type 2 Diabetes
    Kathleen Louise Wyne, Pablo F. Mora · 2007 · Endocrine Research
83. The influence of insulin pump treatment on metabolic syndrome parameters in type 2 diabetes mellitus
    Z Jankovec, D Cechurová, Michal Krčma, S Lacigová, Michal Žourek, Zdeněk Rušavý · 2009 · Wiener klinische Wochenschrift
84. Benefits of early initiation of insulin therapy to long-term goals in type 2 diabetes mellitus
    Aaron I. Vinik · 2006 · Insulin
85. Lispro Is Superior to Regular Insulin in Transient Intensive Insulin Therapy in Type 2 Diabetes
    Yuko Murase, Kunimasa Yagi, Masako Sugihara, Daisuke Chujo, Michio OTSUJI, Hiroaki Muramoto, Hiroshi Mabuchi · 2004 · Internal Medicine
86. A case for introducing insulin early in the treatment of type 2 diabetes mellitus
    Sydney A. Westphal, Pasquale J Palumbo · 2006 · Insulin
87. ‘Insulin should be prescribed at the outset of diagnosis of type 2 diabetes’
    M‐F Kong, Alex S. T. Bickerton · 2011 · Practical Diabetes
88. No Need for the Needle (at First)
    Mayer B. Davidson · 2008 · Diabetes Care
89. Recovery of β -Cell Functions with Low-Dose Insulin Therapy: Study in Newly Diagnosed Type 2 Diabetes Mellitus Patients
    Saptarshi Bhattacharya, Ariachery Chinnama Ammini, Viveka P. Jyotsna, Nandita Gupta, Sadanand N. Dwivedi · 2011 · Diabetes Technology & Therapeutics
90. Oral Agents in Managing Diabetes Mellitus in Children and Adolescents
    Elka E. Jacobson-Dickman, Lynne L. Levitsky · 2005 · Pediatric Clinics of North America
91. The effects of short-term continuous subcutaneous insulin infusion treatment on fasting glucagon-like peptide-1 concentrations in newly diagnosed type 2 diabetes
    Xiaofei Huang, Sha Li, Mei Yang, FU Xu-quan, Huaqi Li, Yan Tong, Yidong Liu, Lihong Chen, Lingsheng Lan, Libo Li et al. · 2018 · Diabetes Research and Clinical Practice
92. Emerging Strategies for the Preservation of Pancreatic Beta-cell Function in early Type 2 Diabetes
    Ravi R. Retnakaran · 2014 · Clinical and investigative medicine
93. Pro's and Con's of the early use of insulin in the management of type 2 diabetes: a clinical evaluation
    Mayer B. Davidson · 2009 · Current Opinion in Endocrinology Diabetes and Obesity
94. Inhaled Human [rDNA Origin] Insulin, a Novel Formulation for Diabetes Mellitus
    David Q. Pham, Henry Cohen, Valery L. Chu · 2007 · The Journal of Clinical Pharmacology
95. Short Course of Insulin Treatment versus Metformin in Newly Diagnosed Patients with Type 2 Diabetes
    Marta Seghieri, Eleni Rebelos, Andrea Mari, Luigi Sciangula, Carlo Bruno Giorda, Ele Ferrannini · 2018 · Journal of Clinical Medicine
96. Global status and trends in type 2 diabetes remission from 2002 to 2022: A bibliometric and visual analysis
    Yang Liu, Xiaokun Gang, Yuan Gao, Yingxuan Wang, Guixia Wang · 2025 · Medicine
97. Early insulin therapy and the risk of cardiovascular disease in Type 2 diabetes
    John Nicasio, Samy I. McFarlane · 2005 · Therapy
98. Practical application of short-term intensive insulin therapy based on the concept of “treat to target” to reduce hypoglycaemia in routine clinical site
    Koji Nakashima, Nobuhiro Okamura, H. Sanefuji, H. Kaneto · 2020 · Scientific Reports
99. Effects of intensive insulin therapy upon pancreatic β cell function in patients newly diagnosed with type II diabetes.
    Defeng Wang, Li Sun, Guangyao Song, Shuchun Chen · 2015 · Europe PMC (PubMed Central)
100. Improvement in insulin sensitivity following intensive insulin therapy and association of glucagon with long-term diabetes remission
     Bo Zhang, Yanyan Chen, Zhaojun Yang, Xin Wang, Guangwei Li · 2016 · Journal of International Medical Research